SU Chun-xia, ZHAO Jing, ZHOU Fei, YANG Xiao-rong. Application of Second-Generation ALK Inhibitor Brigatinib in ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(4): 221-224. DOI: 10.12019/j.issn.1671-5144.2019.04.006
|
Citation:
|
SU Chun-xia, ZHAO Jing, ZHOU Fei, YANG Xiao-rong. Application of Second-Generation ALK Inhibitor Brigatinib in ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(4): 221-224. DOI: 10.12019/j.issn.1671-5144.2019.04.006
|
SU Chun-xia, ZHAO Jing, ZHOU Fei, YANG Xiao-rong. Application of Second-Generation ALK Inhibitor Brigatinib in ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(4): 221-224. DOI: 10.12019/j.issn.1671-5144.2019.04.006
|
Citation:
|
SU Chun-xia, ZHAO Jing, ZHOU Fei, YANG Xiao-rong. Application of Second-Generation ALK Inhibitor Brigatinib in ALK-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(4): 221-224. DOI: 10.12019/j.issn.1671-5144.2019.04.006
|
DownLoad: